Spontaneous perforation of the terminal ileum in an AIDS patient on highly active antiretroviral therapy with disseminated non-tuberculous mycobacterial infection  by Kawana, Masataka et al.
Spontaneous perforation of the terminal ileum in
an AIDS patient on highly active antiretroviral
therapy with disseminated non-tuberculous
mycobacterial infection
Masataka Kawana a, Rebecca S. Starr a, Karen T. Tashima a,b,
Diana O. Treaba c, Timothy P. Flanigan a,b,*
International Journal of Infectious Diseases (2008) 12, 603—606
http://intl.elsevierhealth.com/journals/ijidaDepartment of Medicine, The Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA
bDivision of Infectious Diseases, The Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA
cDepartment of Pathology, The Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA
Received 14 August 2007; received in revised form 4 December 2007; accepted 10 December 2007
Corresponding Editor: Craig Lee, Ottawa, CanadaKEYWORDS
Non-tuberculous
mycobacteria;
MAC;
Opportunistic infections;
Bowel perforation;
GI tuberculosis;
Granulomatous disease
of the bowel
Summary
Background: Despite the impact of highly active antiretroviral therapy (HAART), mycobacterial
infections in patients with AIDS remain a frequent complication. In disseminated cases, both
tuberculous and non-tuberculous mycobacterial infections may involve the gastrointestinal
system and cause abdominal pain and diarrhea. While there have been cases of small bowel
perforation in AIDS patients with Mycobacterium tuberculosis (MTB) infection, no case of bowel
perforation in non-tuberculous mycobacterial (NTM) infection has been reported to date.
Case report: We report a case of spontaneous perforation of the terminal ileum in an AIDS patient
with disseminated non-tuberculous mycobacterial infection who was responding to HAART.
Conclusions: Non-tuberculous mycobacteria can lead to spontaneous bowel perforation in
patients with AIDS who are responding to HAART.
# 2008 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights
reserved.Introduction
Patients infected with HIV are at high risk to develop active
disease with both Mycobacterium tuberculosis (MTB) and* Corresponding author. Tel.: +1 401 793 7152; fax: +1 401 793 4049.
E-mail address: Timothy_Flanigan@brown.edu (T.P. Flanigan).
1201-9712/$32.00 # 2008 International Society for Infectious Diseases.
doi:10.1016/j.ijid.2007.12.013non-tuberculous mycobacteria (NTM).1 In disseminated
cases, both species cause gastrointestinal involvement pre-
senting with abdominal pain and diarrhea. Most NTM are
found in wet soil, natural waters, and even in tap water.2,3
Of note,Mycobacterium avium complex (MAC) is known to be
one of several common opportunistic infections in advanced
AIDS patients when the CD4 count is less than 50 cells/mm3,
and the gut is the portal of entry of the organisms in >90% ofPublished by Elsevier Ltd. All rights reserved.
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Figure 2 Kinyoun staining of the section from the perforated
terminal ileum showing locally increased numbers of acid-fast
bacilli (examples shownwith arrows) — a pattern most consistent
with Mycobacterium avium complex. High-power view.
Figure 1 The site of perforation in the terminal ileum showing
an area of hemorrhagic necrosis with granulation tissue and
acute inflammatory infiltrate, and a wall defect consistent with
focal perforation. Low-power view.the cases.4 Although the incidence of NTM such as MAC
infection has been decreasing in the era of highly active
antiretroviral therapy (HAART),5,6 it remains a major com-
plication in patients who have difficulty adhering to the drug
regimen, in those for whom the drug regimen has failed, and
for those who are restoring their immune system with suc-
cessful HAART.7
We present herein a rare case of spontaneous perforation
of the terminal ileum in an AIDS patient who had dissemi-
nated infection with NTM and had recently resumed HAART.
Case report
A 44-year-old woman with a 12-year history of HIV presented
to The Miriam Hospital after returning from a 1.5-year stay in
Puerto Rico with 70+ lbs (32+ kg) weight loss and generalized
weakness. She had been followed by the Immunology Clinic
but had difficulty with medication adherence. Reportedly,
she did not take antiretrovirals while in Puerto Rico, and her
viral load was greater than 500 000 with a CD4 count of 53.
Upon initial presentation, the patient appeared cachectic
and very weak. While in the hospital she was found to have
multiple enlarged retroperitoneal lymph nodes. Biopsy of the
lymph nodes was performed and preliminary results showed
acid-fast bacilli (AFB) in a pattern most consistent with MAC.
The patient was re-started on anti-retroviral therapy; the
viral load initially decreased from>500 000 to 10 164 and the
CD4 count increased to 63.
Because the AFB culture was not obtained during the first
biopsy, the patient was readmitted for repeat biopsy. Upon
admission, she had diffuse abdominal pain and diarrhea that
was AFB positive. At this point the identification of the
mycobacterial species was still pending, and the patient
was started on a combination of isoniazid, pyrazinamide,
ethambutol, and azithromycin in order to cover not only MAC
but also MTB, given her potential exposures and immunosup-
pression. She was continued on her HAART regimen and her
viral load was 186 copies/ml during this admission.
The patient complained of diffuse abdominal pain since
admission, and morphine was given for pain control. The pain
worsened on day 11 with decreased bowel sounds and a firm
abdomen without rebound tenderness, but an abdominal CT
scan showed no evidence of peritonitis or ileus, and no
significant change in retroperitoneal adenopathy was noted.
The patient was started on an active bowel regimen and
adequate pain control with morphine was continued. On day
15, the patient was started on a prednisone taper because of
a high clinical suspicion for immune reconstitution inflam-
matory syndrome (IRIS).3,8,9 Despite the diffuse abdominal
pain and firm abdomen, the patient felt relatively well until
day 19, when she developed severe abdominal pain with
peritoneal signs. This time, a CTscan showedmultiple enhan-
cing loculated fluid collections in the peritoneal cavity of the
abdomen and pelvis, suggesting peritonitis. Ileus was noted,
likely secondary to the peritonitis, and she was emergently
taken to the operating room. During the exploration of the
lower gastrointestinal tract, there was evidence of a small
bowel obstruction with spontaneous perforation of the term-
inal ileum. The appendix and transverse colon were intact.
The abscesses were drained, and the terminal ileum and
appendix were resected for histological examination. The
patient tolerated the operation and recovered in the inten-sive care unit. She remained intubated and was on pressors
initially, but was extubated uneventfully and transferred to
the floor in a stable condition.
Upon gross examination of the surgical pathology samples,
there was a portion of the terminal ileum that was dilated
and paper-thin, with an irregular defect measuring
2.0  0.8 cm, and the remainder of the small bowel showed
thickening of the wall with slight narrowing of the lumen.
Focal hemorrhage was noted in the serosa and mucosa, and
no obvious lymph nodes were identified. Microscopic exam-
ination of the small bowel site of defect revealed an area of
almost transmural necrosis with granulation tissue and acute
inflammatory infiltrate, consistent with focal spontaneous
perforation (Figure 1). While granulomas were not identified
in any of the sections examined, the Kinyoun stain high-
lighted focally increased numbers of AFB, in a pattern most
consistent with MAC (Figure 2). A nucleic acid amplification
test was negative for MTB, and further speciation of this NTM
was attempted at both the Rhode Island Department of
Health and Centers for Disease Control and Prevention
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exact species at this time.
Discussion
This is a rare case of spontaneous perforation of the terminal
ileum in an AIDS patient with NTM infection who had been
responding to HAART. MAC is a common cause of ‘infectious’
diarrhea that often involves abdominal pain and weight loss in
patients with AIDS.10 MAC may cause nonspecific mucosal
inflammation, edema, ulceration, and thickening of themuco-
sal folds. While there have been cases of ileal perforation by
MTB11,12 and peritonitis caused by MAC in patients who had
ascites,13,14 no case of actual perforation of bowel wall sec-
ondary to MAC or any NTM infection has been reported. The
present case demonstrated clusters of NTM in the perforated
region of the bowel wall in a patternmost consistent with MAC
(Figure 2), and pathological findings were consistent with
spontaneous perforation rather than other iatrogenic damage
during exploratory laparotomy. The inflammatory lesion may
have been greatly exacerbated by IRIS. Also, the steroid
therapy for presumed IRIS may have masked many of the
symptoms of perforation. Disseminated NTM infection may
manifest as a severe abdominal complication, especially in
the period of HAARTwhen the immune system is restoredwhile
the patient may still be chronically ill.
A top priority for treatment in this patient was HAART. The
defense mechanism for mycobacteria relies heavily on pha-
gocytosis and intracellular digestion of the organisms in
macrophages as well as cell-mediated killing by NK cells.4
In advanced AIDS patients, not only do they have impaired
cell-mediated defense mechanisms, but also the intracellu-
lar killing ability is impaired mainly due to insufficient cyto-
kine production to activate macrophages.15 In patients with
HIV, MAC organisms are noted in both intracellular and
extracellular locations. This is why even the appropriate
antibiotic regimen takes 2—4 weeks to reduce the quantity
of organisms.16 In our case, the patient already had a severe
symptomatic infection on presentation and empiric treat-
ment was started for both tuberculous and non-tuberculous
mycobacteria.
Despite the continuous HAART and anti-mycobacterial
treatment, the patient continued to be unstable, with
abdominal pain, cycles of constipation and diarrhea, fever,
and weight loss. At this point IRIS was suspected in the
presence of active mycobacterial infection. IRIS is a clinical
diagnosis characterized by a reactivation of subclinical/pre-
existing opportunistic infections in HIV-infected patients as a
direct result of the enhancement of immune responses to
those pathogens during HAART.8 The temporal association
between commencement of HAART and reduction in periph-
eral viral load supports a diagnosis of IRIS. By definition, hosts
that have successfully restored their immune system intro-
duce inflammatory responses to the infected sites. Philips
et al. reported a variety of symptoms in NTM-IRIS,9 including
13 cases of abdominal involvement. All of the cases had intra-
abdominal nodal involvement, and while four cases had
clinical peritonitis, no case of intestinal perforation was
reported.
Antigens that trigger IRIS may be in the form of viable
organisms, dead organisms, or shed antigen. Mycobacterial
organisms and their components tend to persist in host tissuesfor weeks after initiation of treatment, which favors the high
frequency of IRIS in this particular opportunistic infection.8 It
is also notable that a lack of a rise in blood CD4 lymphocyte
count does not indicate that there has been no restoration of
T-lymphocyte responses, and therefore is not essential for
the diagnosis of IRIS. Rather, a positive response reflected by
a falling viral load is invariably seen and is probably a better
indicator.8
Currently there are no guidelines for the treatment of IRIS
dueto the lackof a clear-cut casedefinitionand its self-limited
natural history. In the present case, with the worsening symp-
toms, prednisone treatment was initiated. The viral load
decreased from 10 164 to 186, which further confirmed the
highly effective HAART regimen and gave us the basis for
initiation of prednisone. The patient eventually had the acute
abdominal emergency on day 2 of 30-mg prednisone treat-
ment. The perforation of terminal ileum was caused by an
inflammatory response to the bowel wall by the host (Figure 1)
due to NTM. Diagnosis is often delayed because symptoms of
peritonitis are often muted by steroids,17 and therefore close
attention must be given to immunocompromised patients.
In summary, we have presented a rare case of spontaneous
perforation of the terminal ileum in an advanced AIDS patient
with non-tuberculous mycobacterial infection who had been
responding to the HAARTregimen. The diagnosis and etiology
of the perforation was caused by the NTM in the gut wall,
steroid use, and possible IRIS.
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